Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Immediacy Index: 0.927
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 605
  • Print this page
  • Email this page
PERSPECTIVE
Year : 2021  |  Volume : 14  |  Issue : 10  |  Page : 431-432

Nix-TB and ZeNix trials: Paving the way for shorter regimens for drug-resistant tuberculosis


Department of Respiratory Medicine, Indira Gandhi Government Medical College, Nagpur, Maharashtra, India

Correspondence Address:
Gyanshankar Mishra
Department of Respiratory Medicine, Indira Gandhi Government Medical College, Nagpur, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1995-7645.329004

Rights and Permissions



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1952    
    Printed36    
    Emailed0    
    PDF Downloaded502    
    Comments [Add]    
    Cited by others 1    

Recommend this journal